SALIX PHARMACEUTICALS LTD Interest Expense
SALIX PHARMACEUTICALS LTD reported Interest Expense of $170.78 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD interest expense for the quarter ending 2014-12-31 was $42.63M, a 170.83% increase year-over-year.
- SALIX PHARMACEUTICALS LTD interest expense for the quarter ending 2014-09-30 was $43.62M, a 181.49% increase year-over-year.
- SALIX PHARMACEUTICALS LTD interest expense for the quarter ending 2014-06-30 was $42.44M, a 174.55% increase year-over-year.
- SALIX PHARMACEUTICALS LTD interest expense for the quarter ending 2014-03-31 was $42.71M, a 178.60% increase year-over-year.
- SALIX PHARMACEUTICALS LTD interest expense for fiscal 2014 was $170.78M, a 175.34% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD interest expense for fiscal 2013 was $62.03M, a 11.72% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD interest expense for fiscal 2012 was $55.52M, a 72.84% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD interest expense for fiscal 2011 was $32.12M, a 55.53% increase from fiscal 2010.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $42.63M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $85.63M derived: sum of 2 quarters · filed 2015-03-02 | $128.07M derived: sum of 3 quarters · filed 2015-03-02 | $170.78M 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | $43.62M 10-Q · filed 2014-11-07 | $85.44M derived: sum of 2 quarters · filed 2015-03-02 | $128.15M 10-Q/A · filed 2015-03-02 | $128.53M 10-Q · filed 2014-11-07 | $143.89M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-06-30 | $42.44M 10-Q/A · filed 2015-03-02 | $85.15M 10-Q/A · filed 2015-03-02 | $84.90M 10-Q · filed 2014-08-08 | $100.89M derived: sum of 3 quarters · filed 2015-03-02 | $116.39M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-03-31 | $42.71M 10-Q/A · filed 2015-03-02 | $42.46M 10-Q · filed 2014-05-09 | $58.45M derived: sum of 2 quarters · filed 2015-03-02 | $73.95M derived: sum of 3 quarters · filed 2015-03-02 | $89.41M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-12-31 | $15.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $31.24M derived: sum of 2 quarters · filed 2015-03-02 | $46.70M derived: sum of 3 quarters · filed 2015-03-02 | $62.03M 10-K · filed 2015-03-02 | $61.65M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $15.50M 10-Q/A · filed 2015-03-02 | $30.96M derived: sum of 2 quarters · filed 2015-03-02 | $46.28M 10-Q/A · filed 2015-03-02 | $62.21M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $15.46M 10-Q/A · filed 2015-03-02 | $30.79M 10-Q/A · filed 2015-03-02 | $46.72M derived: sum of 3 quarters · filed 2015-03-02 | $62.41M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $15.33M 10-Q/A · filed 2015-03-02 | $31.26M derived: sum of 2 quarters · filed 2015-03-02 | $46.95M derived: sum of 3 quarters · filed 2015-03-02 | $62.03M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $15.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $31.62M derived: sum of 2 quarters · filed 2015-03-02 | $46.70M derived: sum of 3 quarters · filed 2015-03-02 | $55.52M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $15.69M 10-Q · filed 2013-11-08 | $30.78M derived: sum of 2 quarters · filed 2013-11-08 | $39.59M 10-Q · filed 2013-11-08 | $47.78M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-06-30 | $15.09M 10-Q · filed 2013-08-09 | $23.90M 10-Q · filed 2013-08-09 | $32.09M derived: sum of 3 quarters · filed 2015-03-02 | $40.17M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-03-31 | $8.81M 10-Q · filed 2013-05-10 | $17.00M derived: sum of 2 quarters · filed 2015-03-02 | $25.08M derived: sum of 3 quarters · filed 2015-03-02 | $33.08M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2011-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $16.27M derived: sum of 2 quarters · filed 2015-03-02 | $24.27M derived: sum of 3 quarters · filed 2015-03-02 | $32.12M 10-K · filed 2015-03-02 | ||||
| 2011-09-30 | $8.08M 10-Q · filed 2012-11-08 | $16.08M derived: sum of 2 quarters · filed 2012-11-08 | $23.93M 10-Q · filed 2012-11-08 | $31.36M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $8.00M 10-Q · filed 2012-08-09 | $15.85M 10-Q · filed 2012-08-09 | $23.28M derived: sum of 3 quarters · filed 2013-03-01 | $30.94M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $7.86M 10-Q · filed 2012-05-08 | $15.28M derived: sum of 2 quarters · filed 2013-03-01 | $22.94M derived: sum of 3 quarters · filed 2013-03-01 | $26.84M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $7.43M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $15.09M derived: sum of 2 quarters · filed 2013-03-01 | $18.98M derived: sum of 3 quarters · filed 2013-03-01 | $20.65M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $7.66M 10-Q · filed 2011-11-09 | $11.55M derived: sum of 2 quarters · filed 2011-11-09 | $13.23M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $3.89M 10-Q · filed 2011-08-09 | $5.56M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $1.67M 10-Q · filed 2011-05-10 | |||||||
| 2009-12-31 | $6.75M 10-K · filed 2012-02-28 |